HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 75,000 Value ($000) $5,048 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 53,000 Value ($000) $3,887 Avg Close $66.43 Range $51.78 - $79.50
Q3 2024
Shares 32,349 Value ($000) $1,852 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 43,968 Value ($000) $2,302 Avg Close $43.86 Range $37.73 - $53.00
Q4 2022
Shares 18,354 Value ($000) $1,044 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 31,051 Value ($000) $1,228 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 100,724 Value ($000) $4,432 Avg Close $43.25 Range $36.95 - $48.58
Q1 2021
Shares 64,359 Value ($000) $2,683 Avg Close $45.65 Range $38.80 - $56.40
Q4 2020
Shares 117,716 Value ($000) $5,028 Avg Close $35.95 Range $25.70 - $44.53
Q3 2020
Shares 96,171 Value ($000) $2,527 Avg Close $27.85 Range $25.17 - $29.77
Q2 2020
Shares 46,703 Value ($000) $1,253 Avg Close $22.56 Range $15.89 - $27.22